Net loss of Genpharmasec reported to Rs 0.83 crore in the quarter ended December 2025 as against net profit of Rs 0.76 crore during the previous quarter ended December 2024. Sales rose 369.69% to Rs 39.83 crore in the quarter ended December 2025 as against Rs 8.48 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales39.838.48 370 OPM %-3.118.37 - PBDT-0.671.37 PL PBT-1.331.27 PL NP-0.830.76 PL Powered by Capital Market - Live News

Genpharmasec will hold a meeting of the Board of Directors of the Company on 9 February 2026.Powered by Capital Market - Live News

Net loss of Genpharmasec reported to Rs 1.18 crore in the quarter ended September 2025 as against net profit of Rs 0.70 crore during the previous quarter ended September 2024. Sales rose 441.29% to Rs 32.64 crore in the quarter ended September 2025 as against Rs 6.03 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales32.646.03 441 OPM %-1.441.99 - PBDT-0.230.81 PL PBT-0.800.50 PL NP-1.180.70 PL Powered by Capital Market - Live News

Net profit of Genpharmasec declined 18.00% to Rs 0.82 crore in the quarter ended September 2025 as against Rs 1.00 crore during the previous quarter ended September 2024. Sales rose 446.97% to Rs 31.56 crore in the quarter ended September 2025 as against Rs 5.77 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales31.565.77 447 OPM %1.624.33 - PBDT1.431.07 34 PBT1.391.03 35 NP0.821.00 -18 Powered by Capital Market - Live News

Genpharmasec will hold a meeting of the Board of Directors of the Company on 6 November 2025.Powered by Capital Market - Live News